NovaBay Pharmaceuticals has commercially introduced its optic Avenova Allograft for eyecare professionals in the US. Available through the company's physician-dispensed channel, the optic ...
1d
Statistically significant (p=0.0177) reduction in knee pain at six monthsStatistically significant (p<0.0001) maintenance of function at six ...
FORT WORTH, Texas, April 19, 2024 /PRNewswire/ -- Legacy Medical Consultants (LMC) announces its newest product portfolio addition with the recent Q code approval for Reeva FT™, a terminally ...
Warren Fingrut, MD, discussed a study looking at HLA antibody burden among patients with blood cancers, particularly women ...
ALACHUA, Fla. and TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, ...
Incorporating the chemokines in a model strongly detected clinically relevant rejections warranting biopsy and, if confirmed, antirejection treatment.
May 2, 2024 LeMaitre Vascular, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third ...
Two studies have reported promising results on the use of rituximab for the treatment of graft rejection in pediatric and young adult renal transplant recipients. Billing et al.'s pilot study ...
Aurora Spine saw fourth quarter growth in 2023, according to financial results posted April 29. 1. Fourth quarter revenue grew 12% year-over-year with $4.04 million. Revenue in 2023 hit $14.52 million ...
The dental industry across the Asia Pacific region reached US$ 10,518.7 million in 2023. Over the forecast period, the Asia ...
Good day, ladies and gentlemen. Welcome to the lawmakers vascular First Quarter 2024 financial results conference call. As a reminder, today's call is being recorded. At this time, I would like to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback